Sequencing Considerations in the Third-Line Treatment of Metastatic Colorectal Cancer
ABSTRACT Numerous advances in the standard of care for metastatic colorectal cancer (mCRC), including the approval of several new treatments indicated for treatment in the third line or later (3L+), have been made, yet data and appropriate guidance on the …